Cargando…
Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies
The need for novel therapeutics against human cancers such as leukemias and solid tumors is well recognized. Human T cells are poised to make a fundamental change in the therapeutic approach. T-cell interaction with a tumor cell is a critical event and primarily driven by T-cell receptor (TCR) recog...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975006/ https://www.ncbi.nlm.nih.gov/pubmed/35402807 http://dx.doi.org/10.1097/BS9.0000000000000032 |